急性呼吸窘迫综合征临床治疗观察及预后影响因素分析  

Clinical Observation of Acute Respiratory Distress Syndrome and Analysis of Prognostic Factors

作　　者：谢才德[1] 秦蓁[1] 邹华兰[1] 罗学彬[1] 李循律[1] 

机构地区：[1]重庆市第九人民医院呼吸内科,重庆400700

出　　处：《现代生物医学进展》2012年第25期4921-4923,共3页Progress in Modern Biomedicine

摘　　要：目的：观察急性呼吸窘迫综合征临床治疗效果,并对预后影响因素进行分析。方法：回顾性分析2006年3月~2011年10月在我院接受治疗的56例急性呼吸窘迫综合征患者的临床资料,使用SPSS12.0进行统计分析,并进行多因素Logistic回归分析。结果：采用以PEEP为主的综合治疗,并联合使用血必净注射液和乌司他丁,治疗ARDS病死率为26.8%;预后影响因素中ARDS并发MODS、APACHEⅡ评分和发病至接受治疗时间具有显著意义。结论：该治疗方法病死率较低,效果良好;ARDS并发并发MODS、APACHEⅡ评分和发病至接受治疗时间是影响ARDS患者的病死预后主要因素。Objective： To observe the clinical results of acute respiratory distress syndrome,and analyze prognostic factors.Methods： During the period March 2006 to October 2011,56 cases of the acute respiratory distress syndrome patients were performed.Their clini-cal data has been analyzed wirh SPSS12.0,and then Logistic regression analysis has been used for it.Results： Patient has been compre-hensively treated on the base of PEEP with combining xuebijing injection and ulinastatin.Its fatality is 26.8%.It has remarkable signifi-cance such as ARDS concurrent MODS,APACHEⅡ score,and time during the period sick to being treated.Conclusions： The treatment is well.It was the main prognostic factors such as ARDS concurrent MODS,APACHEⅡ score,and time during the period sick to being treated.

关 键 词：产后出血 临床观察 致病机理 

分 类 号：R563[医药卫生—呼吸系统]